Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5U3X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,322
Award facts
- Contract value 100% obligated
- $57,321.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $57,321.83 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying a wide range of brand-name and generic medications to military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurements for specialized pharmaceutical products across multiple therapeutic domains. This particular award for Dupixent, a brand-name biologic medication, supports the Defense Health Agency and broader Defense Department healthcare requirements. The company's role as a prime vendor within the DLA's pharmaceutical supply chain reflects its established position as a major healthcare solutions provider serving federal medical needs.
Quick answers
Who was awarded contract SPE2DR26F5U3X?
SPE2DR26F5U3X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F5U3X worth?
The government has obligated $57,322 on SPE2DR26F5U3X.
Is contract SPE2DR26F5U3X an order under another contract?
Yes. SPE2DR26F5U3X is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5U3X competed?
The extent of competition for SPE2DR26F5U3X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award